The Cysteine-Containing Cell-Penetrating Peptide AP Enables Efficient Macromolecule Delivery to T Cells and Controls Autoimmune Encephalomyelitis
T cells are key immune cells involved in the pathogenesis of several diseases, rendering them important therapeutic targets. Although drug delivery to T cells is the subject of continuous research, it remains challenging to deliver drugs to primary T cells. Here, we used a peptide-based drug deliver...
Main Authors: | Won-Ju Kim, Gil-Ran Kim, Hyun-Jung Cho, Je-Min Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1134 |
Similar Items
-
In Vivo Induction of Regulatory T Cells Via CTLA‐4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse
by: Gil‐Ran Kim, et al.
Published: (2021-07-01) -
Treatment of experimental autoimmune encephalomyelitis using AAV gene therapy by blocking T cell costimulatory pathways
by: Chen Zhong, et al.
Published: (2022-06-01) -
Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation
by: Huan-Li Yang, et al.
Published: (2021-09-01) -
Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide
by: Woo-Sung Lee, et al.
Published: (2023-09-01) -
Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides
by: Tingting Lin, et al.
Published: (2016-07-01)